SCHEMBL27078054

SCHEMBL27078054

CC(C)Oc1cccc(C2(C(=O)O)CCOCC2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.52
▸ KMT2A Q03164 2/20 0.44
▸ RXRA P19793 1/20 0.42
▸ RXRB P28702 1/20 0.42
▸ ALOX5 P09917 2/20 0.41
▸ LMNA P02545 4/20 0.41
▸ TSHR P16473 3/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ MMP1 P03956 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ MMP14 P50281 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29705723 1.00 ALDH1A1 (0.52) ALDH1A1KMT2ARXRARXRBALOX5
SCHEMBL28941554 0.87 ALDH1A1 (0.47) ALDH1A1KMT2AALOX5LMNATSHR
SCHEMBL1626965 0.86 ICMT (0.48) ALDH1A1KMT2AMEN1HTTSMN1; SMN2
SCHEMBL23164287 0.83 KMT2A (0.47) ALDH1A1KMT2AALOX5LMNATSHR
SCHEMBL29705586 0.83 KMT2A (0.47) ALDH1A1KMT2AALOX5LMNATSHR
SCHEMBL23164169 0.79 ALDH1A1 (0.51) ALDH1A1KMT2ARXRARXRBLMNA
SCHEMBL23164167 0.79 ALDH1A1 (0.51) ALDH1A1KMT2ARXRARXRBLMNA
SCHEMBL29705585 0.79 ALDH1A1 (0.51) ALDH1A1KMT2ARXRARXRBLMNA
SCHEMBL9911073 0.79 HDAC4 (0.52) ALDH1A1KMT2ALMNATSHRCYP2C19
SCHEMBL7807445 0.78 ALDH1A1 (0.54) ALDH1A1KMT2AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4038052-B1 PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS DOMAIN THERAPEUTICS (FR) 2024-02-07 — — EP disclosed
CN-114555573-A Prostaglandin E2(PGE2)EP4Receptor antagonists 多曼治疗学公司 2022-05-27 — — CN disclosed
Send feedback